Browse by author
Lookup NU author(s): Professor Mark BakerORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016 The Fellowship of Postgraduate Medicine. Background Physicians can come across patients who are exposed to certain prescription drugs or toxins that can result in adverse effects and complications which have high rates of morbidity and mortality. Objective To summarise the key clinical features and management of the common movement disorder toxidromes relevant to physicians (with an interest in neurology). Methods We searched PUBMED from 1946 to 2016 for papers relating to movement toxidromes and their treatment. The findings from those studies were then summarised and are presented here. Results The key features of 6 of the common movement disorder toxidromes and their treatment are tabulated and highlighted. The management of toxidromes with the highest mortality like neuroleptic malignant syndrome and serotonin syndrome are discussed in detail. Conclusion There are several toxidromes that have the potential to become a serious life-threatening emergency if there is a delay in recognition of key clinical features and instituting the appropriate treatment at the earliest is crucial.
Author(s): Malek N, Baker MR
Publication type: Article
Publication status: Published
Journal: Postgraduate Medical Journal
Year: 2017
Volume: 93
Issue: 1100
Pages: 326-332
Print publication date: 01/06/2017
Online publication date: 07/10/2016
Acceptance date: 14/09/2016
ISSN (print): 0032-5473
ISSN (electronic): 1469-0756
Publisher: BMJ Publishing Group
URL: https://doi.org/10.1136/postgradmedj-2016-134254
DOI: 10.1136/postgradmedj-2016-134254
Altmetrics provided by Altmetric
